Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US

References

• BaigentCBlackwellLEmbersonJCholesterol Treatment Trialists’ (CTT) CollaborationEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsLancet201037697531670168121067804
   PubMed Web of Science ®Google Scholar
• CatapanoALReinerZDe BackerGEuropean Society of Cardiology (ESC); European Atherosclerosis Society (EAS)ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the Euro-pean Atherosclerosis Society (EAS)Atherosclerosis2011217134621882396
   PubMed Web of Science ®Google Scholar
• NashDTFillitHCardiovascular disease risk factors and cognitive impairmentAm J Cardiol20069781262126516616038
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIMerzCNCoordinating Committee of the National Cholesterol Education ProgramImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesJ Am Coll Cardiol200444372073215358046
   PubMedGoogle Scholar
• SmithSCAllenJBlairSNAHA/ACCNational Heart, Lung, and Blood InstituteAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood InstituteCirculation2006113192363237216702489
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education ProgramSecond report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)Circulation1994893133314458124825
   PubMed Web of Science ®Google Scholar
• Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation20021063143342112485966
   PubMed Web of Science ®Google Scholar
• GoodmanDSHulleySBClarkLTReport of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArch Intern Med1988148136693422148
   PubMedGoogle Scholar
• International Atherosclerosis SocietyAn International Atherosclerosis Society Position Paper: Global Recommendations for the Management of DyslipidemiaHouston, TXInternational Atherosclerosis Society2013 Available from: http://www.athero.org/IASPositionPaper.aspAccessed January 30, 2014
   Google Scholar
• AndersonTJGregoireJHegeleRAUpdate of the canadian cardiovascular society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultCan J Cardiol201329215116723351925
   PubMed Web of Science ®Google Scholar
• Standards of medical care in diabetes – 2014Diabetes Care201437Suppl 1S14S8024357209
   PubMed Web of Science ®Google Scholar
• BrunzellJDDavidsonMFurbergCDAmerican Diabetes AssociationAmerican College of Cardiology FoundationLipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology FoundationDiabetes Care200831481182218375431
   PubMed Web of Science ®Google Scholar
• JellingerPSSmithDAMehtaAEAACE Task Force for Management of Dyslipidemia and Prevention of AtherosclerosisAmerican Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosisEndocr Pract201218Suppl 1S1S78
   PubMedGoogle Scholar
• StoneNJRobinsonJLichtensteinAH2013ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation Epub11122013
   Google Scholar
• FoodyJMSajjanSGHuXHLoss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patientsJ Clin Lipidol20104212613221122640
   PubMed Web of Science ®Google Scholar
• NicholsGANagSChanWIntensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III updateAm Heart J2007154355456017719305
   PubMed Web of Science ®Google Scholar
• WatersDDBrotonsCChiangCWLipid Treatment Assessment Project 2 InvestigatorsLipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goalsCirculation20091201283419546386
   PubMed Web of Science ®Google Scholar
• CullenMWSteinJHGangnonRMcBridePEKeevilJGNational improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002Am Heart J2008156228429118657658
   PubMed Web of Science ®Google Scholar
• JukemaJWChiangCWFerrièresJLipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2Curr Med Res Opin201026112589259720879831
   PubMed Web of Science ®Google Scholar
• KotsevaKWoodDDe BackerGDe BacquerDPyöräläKKeilUEUROASPIRE Study GroupCardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countriesLancet2009373966792994019286092
   PubMed Web of Science ®Google Scholar
• SantosRDWatersDDTarasenkoLA comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: the Lipid Treatment Assessment Project 2Atherosclerosis2012224115015322818564
   PubMed Web of Science ®Google Scholar
• SteinbergBABhattDLMehtaSNine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular diseaseAm Heart J2008156471972718926153
   PubMed Web of Science ®Google Scholar
• Lipitor^®(atorvastatin calcium) tablets [package insert]New York, NYPfizer, Inc.2012
   Google Scholar
• KaralisDGVictorBAhedorLLiuLUse of lipid-lowering medications and the likelihood of achieving optimal LDL-cholesterol goals in coronary artery disease patientsCholesterol2012201286192422888414
   PubMedGoogle Scholar
• KauffmanABOlsonKLYoungbloodMLZadvornyEBDelateTMerenichJAAttainment of low-density lipoprotein cholesterol goals in coronary artery diseaseJ Clin Lipidol20104317318021122649
   PubMed Web of Science ®Google Scholar
• KitkungvanDLynn FilliponNMDaniSSDowneyBCLow-density lipoprotein cholesterol target achievement in patients at high risk for coronary heart diseaseJ Clin Lipidol20104429329721122662
   PubMed Web of Science ®Google Scholar
• NagSSDanielGWBullanoMFLDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMOJ Manag Care Pharm200713865266317970603
   PubMed Web of Science ®Google Scholar
• MaronDJFazioSLintonMFCurrent perspectives on statinsCirculation2000101220721310637210
   PubMed Web of Science ®Google Scholar
• AronowHDHessGHillJKuznikALiuLZSwitching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterolAm J Ther201017216717519770794
   PubMed Web of Science ®Google Scholar
• AtarDCarmenaRClemmensenPClinical review: impact of statin substitution policies on patient outcomesAnn Med200941424225619191052
   PubMed Web of Science ®Google Scholar
• AthyrosVGTziomalosKKaragiannisAMikhailidisDPTo switch (statins) or not to switch? That is the questionExpert Opin Pharmacother201011182943294620958109
   PubMed Web of Science ®Google Scholar
• JonesPHDavidsonMHSteinEASTELLAR Study GroupComparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)Am J Cardiol200392215216012860216
   PubMed Web of Science ®Google Scholar
• MikhailidisDPSibbringGCBallantyneCMDaviesGMCatapanoALMeta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapyCurr Med Res Opin20072382009202617659159
   PubMed Web of Science ®Google Scholar
• TunceliKSajjanSGRameyDRSwitching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patientsJ Clin Lipidol20104649150021122696
   PubMed Web of Science ®Google Scholar
• WilleyVJBullanoMFShoetanNNGandhiSKTherapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatinCurr Med Res Opin201026112112819916706
   PubMed Web of Science ®Google Scholar
• BodenWEProbstfieldJLAndersonTAIM-HIGH InvestigatorsNiacin in patients with low HDL cholesterol levels receiving intensive statin therapyN Engl J Med2011365242255226722085343
   PubMed Web of Science ®Google Scholar
• hps2-thriveorg [homepage on the Internet]Welcome to the HPS2-THRIVE trialUniversity of Oxford Clinical Trial Service Unit (CTSU)2013 [updated May 2, 2013]. Available from: http://www.hps2-thrive.org/Accessed January 31, 2013
   Google Scholar
• Accord Study Group; GinsbergHNElamMBLovatoLCEffects of combination lipid therapy in type 2 diabetes mellitusN Engl J Med2010362171563157420228404
   PubMed Web of Science ®Google Scholar
• CaliffRMLokhnyginaYCannonCPAn update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) designAm Heart J2010159570570920435175
   PubMed Web of Science ®Google Scholar
• RobertsWCThe rule of 5 and the rule of 7 in lipid-lowering by statin drugsAm J Cardiol19978011061079205036
   PubMed Web of Science ®Google Scholar
• Crestor^®(rosuvastatin calcium) tablets [package insert]Wilmington, DEAstraZeneca Pharmaceuticals LP2012
   Google Scholar
• CatapanoATothPPTomassiniJETershakovecAMThe efficacy and safety of ezetimibe co-administered with statin therapy in various patient groupsClinical Lipidol2013811341
   Web of Science ®Google Scholar
• Liptruzet^®(ezetimibe/atrovastatin) tablets [package insert]Whitehouse Station, NJMerck and Co, Inc2013
   Google Scholar
• Vytorin^®(ezetimibe/simvastatin) tablets [product insert]Whitehouse Station, NJMerck and Co, Inc2012
   Google Scholar
• TothPPCatapanoATomassiniJETershakovecAMUpdate on the efficacy and safety of combination ezetimibe plus statin therapyClinical Lipidol201055655684
   Web of Science ®Google Scholar
• BaysHEAvernaMMajulCEfficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemiaAm J Cardiol2013112121885189524063830
   PubMed Web of Science ®Google Scholar
• FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
   PubMed Web of Science ®Google Scholar